Joshua Elliott Lewis, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow | 4 | 2024 | 2916 | 1.370 |
Why?
|
| Radiation Tolerance | 2 | 2021 | 475 | 0.760 |
Why?
|
| NADP | 3 | 2021 | 228 | 0.740 |
Why?
|
| Hematology | 1 | 2023 | 243 | 0.660 |
Why?
|
| Naphthoquinones | 1 | 2017 | 61 | 0.570 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 740 | 0.560 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2019 | 347 | 0.540 |
Why?
|
| NAD | 1 | 2019 | 618 | 0.470 |
Why?
|
| Bone Marrow Examination | 2 | 2024 | 155 | 0.430 |
Why?
|
| Neoplasms | 5 | 2023 | 22344 | 0.390 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 1926 | 0.370 |
Why?
|
| Radiation, Ionizing | 2 | 2021 | 250 | 0.320 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3594 | 0.320 |
Why?
|
| Genome, Human | 1 | 2021 | 4443 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 3637 | 0.290 |
Why?
|
| Models, Genetic | 1 | 2017 | 3448 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 8924 | 0.260 |
Why?
|
| Cytogenetics | 1 | 2023 | 197 | 0.210 |
Why?
|
| Flow Cytometry | 2 | 2023 | 5881 | 0.210 |
Why?
|
| Hematologic Tests | 1 | 2023 | 239 | 0.200 |
Why?
|
| Atlases as Topic | 1 | 2021 | 247 | 0.170 |
Why?
|
| Cell Count | 1 | 2023 | 1825 | 0.150 |
Why?
|
| Immunophenotyping | 1 | 2023 | 1865 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2021 | 2221 | 0.150 |
Why?
|
| Survival | 1 | 2017 | 160 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 798 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 2144 | 0.130 |
Why?
|
| Thermodynamics | 1 | 2017 | 577 | 0.130 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1756 | 0.110 |
Why?
|
| Acute Disease | 1 | 2023 | 7237 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 17071 | 0.100 |
Why?
|
| Biopsy | 1 | 2024 | 6768 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 2054 | 0.090 |
Why?
|
| Humans | 13 | 2024 | 766117 | 0.090 |
Why?
|
| Kinetics | 1 | 2017 | 6273 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2662 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2021 | 10087 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8612 | 0.070 |
Why?
|
| Cell Survival | 1 | 2017 | 5747 | 0.070 |
Why?
|
| Proteomics | 1 | 2017 | 3907 | 0.050 |
Why?
|
| Software | 1 | 2017 | 4463 | 0.050 |
Why?
|
| Melanoma | 1 | 2020 | 5695 | 0.050 |
Why?
|
| Genomics | 1 | 2017 | 5926 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 817 | 0.040 |
Why?
|
| Glutathione | 1 | 2020 | 589 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2023 | 1527 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 65219 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 29912 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 23605 | 0.030 |
Why?
|
| Antioxidants | 1 | 2020 | 1671 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2023 | 3466 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3214 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 4556 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 3722 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3140 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2353 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 223139 | 0.020 |
Why?
|
| Computational Biology | 1 | 2020 | 3565 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10737 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2023 | 4857 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14645 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5336 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13635 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 81565 | 0.010 |
Why?
|